立体定向放疗治疗单发脑转移瘤后放射性坏死的预测:单变量模型外部验证与多变量模型开发
本研究回顾性纳入162例接受立体定向放疗的单发脑转移瘤患者,外部验证基于健康脑组织接受≥12 Gy体积的NTCP模型预测放射性坏死的效能。结果显示该模型区分度不足(C统计量0.61),而肿瘤体积和健康脑组织接受≥12 Gy体积在单变量分析中与症状性放射性坏死相关,多变量分析中不显著。研究者建立并内部验证了新的多因素列线图,尚需外部验证。
要点
- 原NTCP模型预测任何放射性坏死和症状性放射性坏死的C统计量均为0.61,临床实用性不足。
- 单变量分析中肿瘤体积和健康脑组织接受≥12 Gy体积与症状性放射性坏死显著相关,多变量分析中不显著。
- 新建立的多因素列线图需外部验证后方可用于临床。
核心结论
- 所测试的NTCP模型预测脑转移瘤患者SRT后放射性坏死的准确性不足以用于临床实践。
- 开发了新的多因素列线图预测症状性放射性坏死,该模型需外部验证。
研究设计与样本
- 回顾性纳入162例接受SRT的单发脑转移瘤患者,外部验证NTCP模型,评估区分度(C统计量)和校准度(Brier分数),采用Kaplan-Meier法确定总生存。
主要发现
- 中位总生存期为10个月。
- 44例(27%)患者发生无症状或症状性放射性坏死,其中26例(16%)为症状性放射性坏死,6个月和12个月 actuarial 率分别为11%和22%。
- 「任何放射性坏死」和「症状性放射性坏死」模型的C统计量均为0.61,Brier分数分别为0.201和0.217。
- 单变量logistic回归显示肿瘤体积和健康脑组织接受≥12 Gy体积均与症状性放射性坏死显著相关,但多变量分析中不显著。
- 建立并内部验证了列线图。
关键数值与推荐
- NTCP模型基于健康脑组织接受≥12 Gy的体积预测放射性坏死风险。
- 「任何放射性坏死」模型的C统计量为0.61,Brier分数0.201;「症状性放射性坏死」模型的C统计量为0.61,Brier分数0.217。
临床怎么用
- 现有NTCP模型预测放射性坏死的准确性不足,不建议直接用于临床决策。
- 新列线图可用于预测症状性放射性坏死,但需外部验证后方可临床应用。
局限性
- 回顾性研究设计。
- 新列线图仅进行内部验证,需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Stereotactic radiation therapy (SRT) is a frequently used and effective treatment for patients who received diagnosis for brain metastases (BMs). Radionecrosis (RN) is a severe complication of SRT which may cause neurologic symptoms. A normal tissue complication probability (NTCP) model has previously been established to predict the risk of RN based on the volume of healthy brain receiving ≥12 Gy. The aim of this study is to externally validate this prediction model. METHODS AND MATERIALS: A total of 162 patients treated with SRT for solitary BMs were retrospectively included. The NTCP models for all (asymptomatic and symptomatic) RN and symptomatic RN cases were evaluated using discrimination (C-statistic) and calibration (Brier scores). Overall survival was determined using the Kaplan-Meier method. RESULTS: Median overall survival was 10 months. Asymptomatic or symptomatic RN was found in 44 (27%) of patients. Of these, 26 (16%) RN cases were symptomatic, with actuarial rates of 11% and 22% after 6 and 12 months, respectively. The C-statistics of the "any RN" and the "symptomatic RN" models were identical (0.61). Brier scores were 0.201 and 0.217, respectively. Univariable logistic regression analysis showed a significant correlation between both tumor volume and volume of healthy brain receiving ≥12 Gy with symptomatic RN. These effects did not hold up in the multivariable analysis. A nomogram was established and internally validated. CONCLUSIONS: The accuracy of the tested NTCP models in assessing the risk of RN in patients with BM after SRT was insufficient for clinical practice. A novel multifactorial nomogram was developed to predict symptomatic RN. This model needs to be externally validated.
引用
- van Schaik EEMW, Crouzen JA, Mast ME, et al. Predicting Radionecrosis After Stereotactic Radiation Therapy for Solitary Brain Metastases: External Validation of a Univariable Model and Development of a Multivariable Model. Adv Radiat Oncol. 2025. PMID: 41030686. doi:10.1016/j.adro.2025.101871
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。